A phase I trial of IMC-A12 and temsirolimus in children with refractory solid tumors: A Children’s Oncology Group Study.
M. Fouladi
No relevant relationships to disclose
J. P. Perentesis
No relevant relationships to disclose
L. M. Wagner
No relevant relationships to disclose
A. M. Ingle
No relevant relationships to disclose
J. Gammon
No relevant relationships to disclose
G. Thomas
No relevant relationships to disclose
D. A. Krueger
Consultant or Advisory Role - Novartis (U)
Honoraria - Novartis
Research Funding - Novartis
P. Houghton
No relevant relationships to disclose
S. Vinks
No relevant relationships to disclose
B. Weigel
No relevant relationships to disclose
S. Blaney
No relevant relationships to disclose